Transpek Industry share price today

Transpek Industry Ltd's share price was ₹1,257.40 at the close on 4 November 2026. It has been rising for 8 weeks. That is 2.4% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹909 and ₹1,439, and at that close it sat 66% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Transpek Industry Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 17 weeks in a row.

Over the last 11 years the share price moved +242% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

2. Indian funds and insurers (DIIs) cut their stake for 3 quarters in a row

   From 1.6% to 0.2% of the company by the September 2026 quarter.

3. Revenue down on a year earlier for 4 quarters in a row

   In the June 2026 quarter revenue was ₹151 crore, -2.1% on a year earlier.

   Why: Revenue fell because export demand was weak and the market had too much supply, which kept prices aggressive.

   Next results: check whether revenue growth reaches the stated floor, helped by more acid chloride sales and a pickup in demand.

   From the earnings call on 20 Aug 2026.

For April to June 2026 (the quarter ended 30 June 2026), Transpek Industry reported revenue of ₹151 crore, down 2.1% from ₹154 crore a year earlier, and a profit of ₹8.93 crore, down 42.7% from ₹15.6 crore.

Transpek Industry results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Transpek Industry's management discussed these results on a call held on 20 August 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Transpek Industry closed at ₹1,257.40 on 4 November 2026, down 11.1% from ₹1,415.05 a year earlier (7 November 2025) and down 48.5% over five years. Its highest weekly close since March 2016 was ₹2,440.30 on 4 November 2021.

Transpek Industry share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

562 weekly closes from 11 March 2016 to 4 November 2026.

4 Nov 2026: Transpek Industry closed at ₹1,257.40, up 1.7% on the week and down 4.0% on the month. 7 Sep 2026: ex-date for a dividend of ₹20 a share.

Earlier

• 20 Aug 2026: Transpek Industry held its results call for April to June 2026. Management guided: FY27 revenue growth framed at 15-20%, with at least 15% stated; an added high-volume acid chloride goals about ₹15 crore versus ₹4 crore last year.
• Results for April to June 2026: Revenue down 2.1% and profit down 42.7% on a year earlier.

Transpek Industry paid ₹20 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 1.59% at the ₹1,257.40 close on 4 November 2026. The last was a dividend of ₹20 a share, ex-date 7 September 2026.

Transpek Industry dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Yes. Transpek Industry Ltd paid out 24% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 20 August 2026, Transpek Industry's management guided: FY27 revenue growth framed at 15-20%, with at least 15% stated; an added high-volume acid chloride goals about ₹15 crore versus ₹4 crore last year.

“In those cases, we will invest ahead of having a fully confirmed business. However, for quite a few products, the investment is largely driven by customer requirements. We are no longer going to be as conservative as we were.”Bimal V. Mehta, on the call for April to June 2026

What management guided

• Revenue and business size planned to double over the next 5-6 years through current products and new products.
• First product: 5 metric tonne pilot, 3-4 month trial and year-end sales; second product: FY27-end commercialization, FY28 revenue and about ₹50 crore annual potential each.
• FY27 R&D team and infrastructure to double; Ekalbara multipurpose pilot plant expected ready in 6-7 months, with four reaction streams.
• Odisha project: Board review within 25-30 days; if approved, decision by end-November, permissions in 3-4 months and production after 1.5-2 years; about ₹250 crore over 5-6 years, 4-5-year payback.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 20 August 2026.

When Transpek Industry reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: FY27 revenue growth to reach the stated floor, with added acid-chloride contribution and broader demand recovery visible.

Transpek Industry is on 2 of our India lists: Momentum stocks and Dividend stocks.

Transpek Industry Ltd earned ₹8.9 Cr of net profit in the Jun 2026 quarter, −42.7% on the same quarter a year earlier. Full-year FY26 profit was ₹46.0 Cr. Over 10 years profit has grown 8.2% a year on average. That is 5.9% of the quarter's revenue. The same quarter a year earlier earned ₹15.6 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹46.0 Cr (−6.1% on the year before).

Why profit moved: revenue changed −2.1% on a year earlier and the margin moved −2.3 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed −18.6% and revenue −5.2%. Profit is growing slower than sales: rising costs are taking part of the growth.

Transpek Industry Ltd reported ₹151 Cr of revenue in the Jun 2026 quarter, −2.1% on the same quarter a year earlier. Over 10 years it has grown 8.1% a year on average. The last full year, FY26, came in at ₹621 Cr. The last four reported quarters add to ₹618 Cr.

Revenue is everything the company billed its customers in the period.

FY26 revenue was ₹621 Cr, −4.5% on the year before.

Recent pace: the last four quarters grew −5.2% on average, against 8.1% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew −5.2%, against +4.2% a year over the last 8 quarters (rolling over); profit over the last 12 months grew −29.1%, against +10.4% a year (rolling over).

Transpek Industry Ltd's operating margin was 13.3% in the Jun 2026 quarter, 2.3 percentage points lower than the same quarter a year ago. Across 13 years it has been between 10.0% and 21.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −2.3 percentage points on the year while gross margin changed +1.6 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 232% of Transpek Industry Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹78.0 Cr of operating cash against ₹46.0 Cr of profit. After ₹32.0 Cr of spending on assets, ₹46.0 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 232% of profit came in as cash: the cash cycle got 19 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner.

What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets.

Transpek Industry Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 64 days in FY26, down from 83 days in FY21. It spent ₹96.0 Cr on assets over the last 3 years. Customers take 88 days to pay, and stock sits for 63 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹621 Cr, each day of that cycle ties up about ₹1.7 Cr, so roughly ₹109 Cr is tied up in the business at any time.

FY26: customers took 88 days to pay and stock sat for 63 days, about 2.1 months of sales sitting as stock, for a full cycle of 64 days, shorter than FY21's 83.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 63 days. Customers pay about 88 days after that. Suppliers are paid at 87 days. Together that makes the 64-day cycle.

Spending on assets: ₹96.0 Cr over the last 3 years, against ₹137 Cr of depreciation (the yearly wear and tear on existing assets). So it is spending about what it takes to replace what wears out, or less. Work still in progress is ₹5.0 Cr (FY26): assets paid for that are not earning yet.

In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean.

Transpek Industry Ltd's P/E is 18.0×, in the middle of its own history: higher than 60% of past readings. Its usual P/E (the middle reading) is 15.3×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.